TP53 and cancer: PRIMA-1 (p53 reactivation and induction of massive apoptosis; Figure 2d) and its methylated form PRIMA-1MET have recently emerged as molecules to reverse p53 mutation to wild-type p53 in various cancers such as breast, neck, thyroid, and melanoma [83,84,85,86].